Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / GLOBAL EX US HGH
-
Total 13F shares
-
5,357,375
-
Share change
-
+234,772
-
Total reported value
-
$101,483,369
-
Price per share
-
$18.94
-
Number of holders
-
59
-
Value change
-
+$4,392,011
-
Number of buys
-
25
-
Number of sells
-
30
Institutional Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q3 2022
As of 30 Sep 2022,
INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,357,375 shares.
The largest 10 holders included
Whitcomb & Hess, Inc., ADVISOR GROUP HOLDINGS, INC., Essex LLC, Cerity Partners LLC, CABOT WEALTH MANAGEMENT INC, Sowell Financial Services LLC, Janney Montgomery Scott LLC, AE Wealth Management LLC, Royal Fund Management, LLC, and OLIVER LAGORE VANVALIN INVESTMENT GROUP.
This page lists
59
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.